A detailed history of Prudential PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Prudential PLC holds 22,256 shares of LEGN stock, worth $890,907. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,256
Previous 18,758 18.65%
Holding current value
$890,907
Previous $1.05 Million 6.37%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$39.5 - $57.22 $138,171 - $200,155
3,498 Added 18.65%
22,256 $985,000
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $214,844 - $273,100
3,902 Added 26.27%
18,758 $1.05 Million
Q4 2023

Feb 13, 2024

BUY
$57.25 - $69.74 $340,580 - $414,883
5,949 Added 66.79%
14,856 $893,000
Q3 2023

Nov 09, 2023

BUY
$63.16 - $76.5 $34,359 - $41,616
544 Added 6.5%
8,907 $598,000
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $143,421 - $232,455
3,099 Added 58.87%
8,363 $577,000
Q4 2022

Feb 08, 2023

BUY
$38.8 - $55.46 $204,243 - $291,941
5,264 New
5,264 $262,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.